Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin)

Clinical trial NCT01842126 · COMPLETED

Trial details

NCT number: NCT01842126
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Painful Lumbar Radiculopathy Healthy

Start date: 2013-04-01
Primary completion: 2014-08-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.